CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit ...

CytoSorbents Corporation (NASDAQ: CTSO) and Converge Biotech, a prominent healthcare company with a strong critical care and infectious disease focus in India, are pleased to announce a new strategic ...

Equities researchers at StockNews.com started coverage on shares of Cytosorbents (NASDAQ:CTSO – Get Free Report) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on ...

Cytosorbents Corp ( (CTSO) ) has released its Q3 earnings. Here is a breakdown of the information Cytosorbents Corp presented to its investors.

PRINCETON, N.J. (AP) — PRINCETON, N.J. (AP) — CytoSorbents Corp. (CTSO) on Thursday reported a loss of $2.3 million in its third quarter. The Princeton, New Jersey-based company said it had a loss of ...

PRINCETON, N.J., Nov. 07, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery ...

Adaptive Biotechnologies will host a conference call to discuss its third quarter 2024 financial results after market close ...